Drug-induced lupus erythematosus;Lupus eritematoso inducido por fármacos

Actas Dermo-Sifiliograficas

Volumn 105, Issue 1, 2014, Pages 18-30

  Pretel, M ^a   Marques L ^a   Espana A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Autoimmunity; Drugs; Lupus erythematosus

Indexed keywords

ARTICLE; IDIOPATHIC DISEASE; IDIOPATHIC LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS; LUPUS LIKE SYNDROME; ADVERSE DRUG REACTION; AUTOIMMUNITY; BIOTRANSFORMATION; CHEMICALLY INDUCED; CLASSIFICATION; DRUG SUBSTITUTION; GENETIC PREDISPOSITION; HUMAN; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SYMPTOM ASSESSMENT;

DRUG;

AUTOIMMUNITY; BIOTRANSFORMATION; DRUG SUBSTITUTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHARMACEUTICAL PREPARATIONS; SYMPTOM ASSESSMENT;

EID: 84893089652     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2012.09.025     Document Type: Short Survey

References (107)

1. E. Hess Drug-related lupus N Engl J Med 318 1988 1460 1462
2. R.L. Yung, and B.C. Richardson Drug-induced lupus Rheum Dis Clin North Am 20 1994 61 86
3. N.C. Henningsen, A. Cederberg, A. Hanson, and B.W. Johansson Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators Acta Med Scand 198 1975 475 482
4. H.A. Cameron, and L.E. Ramsay The lupus syndrome induced by hydralazine: a common complication with low dose treatment Br Med J 289 1984 420 422
5. A.T. Borchers, C.L. Keen, and M.E. Gershwin Drug-induced lupus Ann NY Acad Sci 1108 2007 166 182
6. E.L. Dubois Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and follow up of reported cases Medicine (Baltimore) 48 1969 217 228
7. R.L. Woosley, D.E. Drayer, M.M. Reidenberg, A.S. Nies, K. Carr, and J.A. Dates Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome N Engl J Med 298 1978 1157 1159
8. R.L. Rubin Drug-induced lupus Toxicology 209 2005 135 147
9. R.L. Rubin Etiology and mechanism of drug-induced lupus Curr Opin Rheumatol 11 1999 357 363
10. X. Jiang, G. Khursigara, and R.L. Rubin Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils Science 266 1994 810 813
11. R.L. Yung, K.J. Johnson, and B.C. Richardson New concepts in the pathogenesis of drug-induced lupus Lab Invest 73 1995 746 759
12. L. Mazari, M. Ouarzane, and M. Zouali Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus Proc Natl Acad Sci U S A 104 2007 6317 6322
13. R.L. Rubin, and A. Kretz-Rommel Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus Environ Health Perspect 107 1999 803 806
14. A. Kretz-Rommel, S.R. Duncan, and R.L. Rubin Autoinmmunity caused by disruption of central T cell tolerance. A murine model of drug induced lupus J Clin Invest 99 1997 1888 1896
15. J.P. Portanova, R.E. Arndt, E.M. Tan, and V.L. Kotzin Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions J Immunol 138 1987 446 451
16. C.S. Di Fazano, and P. Bertin The pharmacological management of drug-induced rheumatic disorders Expert Opin Pharmacother 10 2001 1623 1631
17. M.F. Costa, N.R. Said, and B. Zimmermann Drug-induced lupus due to anti-tumor necrosis factor a agents Semin Arthritis Rheum 37 2008 381 387
18. P. Caramaschi, D. Biasi, M. Colombatti, S. Pieropan, N. Martinelli, and A. Carletto et al. Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity Rheumatol Int 26 2004 209 214
19. R.D. Sontheimer, L. Clifford, and H. Renee Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient oriented translational clinical investigation Arch Dermatol Res 301 2009 65 70
20. J.P. Callen Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently under-recognised J Am Acad Dermatol 45 2001 315 316
21. F.M. Richards, and W.J. Fulkerson Jr. Constrictive pericarditis due to hydralazine-induced lupus erythematosus Am J Med 88 1990 56N 59N
22. M.A. Siddiqui, and I.A. Khan Isoniazid-induced lupus erythematosus presenting with cardiac tamponade Am J Ther 9 2002 163 165
23. J.T. Hardee, C.A. Roldan, and T.W. Du Clos Betaxolol and drug-induced lupus complicated by pericarditis and large pericardial effusion West J Med 167 1997 106 109
24. J.J. Cush, and E.A. Goldings Drug-induced lupus: Clinical spectrum and pathogenesis Am J Med Sci 290 1985 36 45
25. B.U. Ihle, J.A. Whitworth, J.P. Dowling, and P. Kincaid-Smith Hydralazine and lupus nephritis Clin Nephrol 22 1984 230 238
26. M. Srivastava, A. Rencic, G. Diglio, H. Santana, P. Bonitz, and R. Watson et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus Arch Dermatol 139 2003 45 49
27. G. Bonsmann, M. Schiller, T.A. Lugar, and S. Ständer Terbinafine-induced subacute cutaneous lupus erythematosus J Am Acad Dermatol 44 2001 925 931
28. A.V. Marzano, A. Borghi, M. Mercogliano, M. Facchetti, and R. Caputo Nitrendipine-induced subacute cutaneous lupus erythematosus Eur J Dermatol 13 2003 213 216
29. D. Antonov, J. Kazandjieva, D. Etugov, D. Gospodinov, and N. Tsankov Drug-induced lupus erythematosus Clin Dermatol 22 2004 157 166
30. T. Yoshimasu, A. Hiroi, K. Uede, and F. Furukawa Discoid lupus erythematosus (DEL)-like lesion induced by uracil-tegafur (UFT) Eur J Dermatol 11 2001 54 57
31. A. Rahaman, and D.A. Isenberg Systemic lupus erythematosus N Engl J Med 358 2008 929 939
32. E.A. Hildreth, C.E. Biro, and T.A. McCreary Persistence of the «hydralazine syndrome»: A follow-up study of eleven cases JAMA 173 1960 657 660
33. J.R. Batchelor, K.I. Welsh, R.M. Tinoco, C.T. Dollery, G.R. Hughes, and R. Bernstein et al. Hydralazine-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility Lancet 24 1980 1107 1109
34. B.H. Bass Hydralazine lung Thorax 36 1981 695 696
35. R.L. Rubin Drug-induced lupus D.J. Wallace, B.H. Hahn, Dubois' lupus erythematosus 6th ed. 2002 Lippincott Williams & Wilkins Philadelphia, PA 885 916
36. A.B. Mongey, and E.V. Hess Drug insight: autoimmune effects of medications-what's new? Nat Clin Pract Rheumatol 4 2008 136 144
37. R.L. Rubin, R.W. Burlingame, J.E. Arnott, M.C. Totoritis, E.M. McNally, and A.D. Johnson IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus J Immunol 154 1995 2483 2493
38. D.M. Nordstrom, S.G. West, and R.L. Rubin Methyldopa-induced systemic lupus erythematosus Arthritis Rheum 32 1989 205 208
39. B.L. Jonas, M. Lim, and C.A. Agudelo Chlorpromazine-induced lupus with cardiac tamponade J Clin Rheumatol 1 1995 60 62
40. J. Webb, J. Shilton, and J. Wicks Quinidine-induced lupus erythematosus-like syndrome: three case reports and a review of the literature Med J Aust 149 1988 53 54
41. W.C. Tsai, C.J. Chen, J.H. Yen, and H.W. Liu Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis Clin Rheumatol 21 2002 339 340
42. G.L. Clementz, and B.J. Dolin Sulfasalazine-induced lupus erythematosus Am J Med 84 1988 535 538
43. A.W. Kirkpatrick, A.A. Bookman, and F. Habal Lupus-like syndrome caused by 5-aminosalicylic acid in patients with inflammatory bowel disease Can J Gastroenterol 13 1999 159 162
44. K.K. Jain Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy Drug Saf 6 1991 350 360
45. A. Yamada, K. Sato, M. Hara, A. Tochimoto, S. Takagi, and N. Hizuka et al. Propylthiouracil-induced lupus-like syndrome developing in a Graves' patient with a sibling with systemic lupus erythematosus Inter Med 41 2002 1204 1208
46. W.C. Tsai, C.J. Chen, J.H. Yen, and H.W. Liu Sulphasalazine-induced systemic lupus erythematosus in a patient with ankylosing spondylitis Clin Rheumatol 21 2002 339 340
47. A. Goodrich, and S. Kohn Hydrochlorothiazide-induced lupus erythematosus. A new variant? J Am Acad Dermatol 28 1993 1001 1002
48. M. McGuiness, R.A. Frye, and J.S. Deng Atenolol-induced lupus erythematosus J Am Acad Dermatol 37 1997 298 299
49. D.J. Margolis, O. Hoffstad, and W. Bilker Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus Br J Dermatol 157 2007 540 546
50. C.D. Vedove, M. Del Giglio, D. Schena, and G. Girolomoni Drug-induced lupus erythematosus Arch Dermatol Res 301 2009 99 105
51. R.H. Knitzer, and B. White Needlemann Musculoskeletal syndromes associated with acne Semin Arthritis Rheum 20 1991 247 255
52. R.G. Schlienger, A.J. Bircher, and C.R. Meier Minocycline-induced Dermatology 200 2000 223 231
53. F.A. Borg, and D.A. Isenberg Syndromes and complications of interferon therapy Curr Opin Rheumatol 19 2007 61 66
54. J.C. Crispin, and E. Díaz-Jouanen Systemic lupus erythematosus induced by therapy with interferon-beta in a patient with multiple sclerosis Lupus 14 2005 495 496
55. B. Bonaci-Nikolic, I. Jeremic, S. Andrejevic, M. Sefik-Bukilica, and N. Stojsavljevic Drulovic J Anti-double stranded DNA and lupus syndrome induced by interferon-β therapy in a patient with multiple sclerosis Lupus 18 2009 78 80
56. M.J. Fritzler Drugs recently associated with lupus syndromes Lupus 3 1994 455 459
57. P. Caramaschi, D. Biasi, A. Carletto, T. Manzo, and L.M. Bambara Clobazam-induced systemic lupus erythematosus Clin Rheumatol 14 1995 116
58. P. Sarzi-Putini, B. Pan, M. Cazola, S. Muzzupappa, and M. Turiel Lamotrigine-induced lupus Lupus 9 2000 555 557
59. P.J. Charles, R.J.T. Smeenk, J. De Jong, M. Feldmann, and R.N. Maini Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α Arthritis Rheum 43 2000 2383 2390
60. M. De Bandt, J. Sibilia, X. Le Loet, S. Prouzeau, B. Fautrel, and C. Marcelli et al. Systemic lupus erythematosus induced by antitumour necrosis factor alpha therapy: a French national survey Arthritis Res Ther 7 2005 R545 R551
61. T. Chadha, and J.E. Hernandez Infliximab-related lupus and associated valvulitis: a case report and review of the literature Arthritis Rheum 55 2006 163 166
62. E. Carlson, and N. Rothfield Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis Arthritis Rheum 48 2003 1165 1166
63. A. Mor, C. Bingham 3rd, L. Barisoni, E. Lydon, and H.M. Belmont Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept J Rheumatol 32 2005 740 743
64. M. Ramos-Casals, P. Brito-Zerón, and S. Muñoz Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases Medicine (Baltimore) 86 2007 242 251
65. A. Suess, and M. Sticherling Leflunomide in subacute cutaneous lupus erythematosus: two sides of a coin Int J Dermatol 47 2008 83 86
66. A.V. Marzano, S. Ramoni, N. del Papa, M. Barbareschi, and E. Alessi Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions Lupus 17 2008 329 331
67. D. Rea, A. Bergeron, C. Fieschi, D. Bengoufa, E. Oksenhendler, and H. Dombret Dasatinib-induced lupus Lancet 372 2008 713 714
68. A. Wollenberg, and M. Meurer Thiazide diuretic-induced subacute cutaneous lupus erythematosus Hautarzt 42 1991 709 712
69. P. Berbis, C. Vernay-Vaisse, and Y. Privat Subacute cutaneous lupus observed during treatment with thiazide diuretics Ann Dermatol Venereol 113 1986 1245 1248
70. M.L. Fernández-Díaz, P. Herranz, M.C. Suárez- Marrero, J. Borbujo, R. Manzano, and M. Casado Subacute cutaneous lupus erythematosus associated with cilazapril Lancet 345 1995 398
71. S. Fenniche, A. Dhaoui, F.B. Ammar, R. Benmously, H. Marrak, and I. Mokhtar Acebutolol-induced subacute cutaneous lupus erythematosus Skin Pharmacol Physiol 18 2005 230 233
72. D.A. McKay, O.M. Schofield, and E.C. Benton Terbinafine-induced subacute cutaneous lupus erythematosus Acta Derm Venereol 84 2004 472 474
73. K. Lorentz, N. Booken, S. Goerdt, and M. Goebeler Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature J Dtsch Dermatol Ges 6 2008 823 827 823-8
74. J.P. Callen, A.P. Hughes, and C. Kulp-Shorten Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases Arch Dermatol 137 2001 1196 1198
75. T.B. Cassis, and J.P. Callen Bupropion-induced subacute cutaneous lupus erythematosus Australas J Dermatol 46 2005 266 269
76. G. Guhl, B. Diaz-Ley, C. García-García, J. Fraga, and A. Garcia-Diez Chemotherapy-induced subacute lupus erythematosus Lupus 18 2009 859 860
77. W. Weger, B. Kränke, A. Gerger, W. Salmhofer, and E. Aberer Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine J Am Acad Dermatol 59 2008 S4 S6
78. M. Chen, A.N. Crowson, M. Woofter, M.B. Luca, and C.M. Magro Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases J Rheumatol 31 2004 818 820
79. D.D. Bentley, J.E. Graves, D.I. Smith, and M.P. Heffernan Efalizumab-induced subacute cutaneous lupus erythematosus J Am Acad Dermatol 54 2006 S242 S243
80. A. Bracke, T. Nijsten, J. Vandermaesen, L. Meuleman, and J. Lambert Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases Acta Derm Venereol 85 2005 353 354
81. I. Fumal, A. Danchin, F. Cosserat, A. Barbaud, and J.L. Schmutz Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases Dermatology 210 2005 251 252
82. S. Ross, A.D. Ormerod, C. Roberts, C. Dwyer, and R. Herriot Subacute cutaneous lupus erythematosus associated with phenytoin Clin Exp Dermatol 27 2002 474 476
83. C. Lazaro Subacute cutaneous lupus erythematosus associated with oxcarbazepine Med Cutan Iber Lat Am 34 2006 127 129
84. J.M. Martín Lupus eritematoso cutáneo subagudo inducido por fármacos Actas Dermosifiliogr 95 2004 117 119
85. G.S. Bleumink, E.J. ter Borg, C.G. Ramselaar, and B.H. Ch Stricker Etanercept-induced subacute cutaneous lupus erythematosus Rheumatology (Oxford) 40 2001 1317 1319
86. F. Merlin, T. Prochilo, B. Kildani, C. Lombardi, G. Pasolini, and F. Bonetti et al. Discoid lupus erythematosus (DEL)-like lesions induced by capecitabine Int J Colorectal Dis 23 2008 715 716
87. S.W. Schneider, S. Staender, B. Schluter, T.A. Luger, and G. Bonsmann Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis Arch Dermatol 142 2006 115 116
88. S. Sohl, R. Renner, U. Winter, M. Bodendorf, U. Paasch, and J.C. Simon et al. Drug-induced lupus erythematosus tumidus during treatment with adalimumab Hautarzt 60 2009 826 829
89. C. Schepis, M. Lentini, M. Siragusa, and D. Batolo ACE-inhibitor-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus Dermatology 208 2004 354 355
90. Y.T. Lin, Y.C. Chang, R.C. Hui, C.H. Yang, H.C. Ho, and S.I. Hung et al. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions J Eur Acad Dermatol Venereol 2012
91. R.L. Rubin, and S. Waga Antihistone antibodies in systemic lupus erythematosus J Rheumatol 135 1987 118 126
92. M. El-Hallak, T. Giani, B.S. Yeniay, K.E. Jacobs, S. Kim, and R.P. Sundel et al. Chronic minocycline-induced autoimmunity in children J Pediatr 153 2008 314 319
93. B. Haraoui, and E. Keystone Musculoskeletal manifestations and autoimmune diseases related to new biologic agents Curr Opin Rheumatol 18 2006 96 100
94. M. Gioud, M.A. Kaci, and J.C. Monier Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool Arthritis Rheum 25 1982 407 413
95. W.G. Cohen, and J. Webb Antihistone antibodies in rheumatoid arthritis and Felty's syndrome Arthritis Rheum 32 1989 1319 1324
96. P. Malleson, R.E. Petty, M. Fung, and E.P. Candido Reactivity of antinuclear antibodies with histones and other antigens in juvenile rheumatoid arthritis Arthritis Rheum 32 1989 919 923
97. D.P. Molden, G.L. Klippe, C.L. Puebles, R.L. Rubin, R.M. Nakamura, and E.M. Tan IgM-anti-histone H-3 antibody associated with undifferentiated rheumatic disease syndromes Arthritis Rheum 29 1986 39 46
98. J.P. Portanova, R.E. Arndt, E.M. Tan, and B.L. Kotzin Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions J Immunol 138 1987 446 451
99. G.Q. Shen, Y. Shoenfeld, and J.B. Peter Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus Clin Rev Allergy Immunol 16 1998 321 334
100. M.C. Totoritis, E.M. Tan, E.M. Mc Nally, and R.L. Rubin Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus N Engl J Med 318 1988 1431 1436
101. A. Epstein, and P. Barland The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus Arthritis Rheum 28 1985 148 162
102. L. Grossman, and P. Barland Histone reactivity of drug-induced anti-nuclear. A comparison of symptomatic and asymptomatic patients Arthritis Rheum 24 1981 927 931
103. A.T. Borchers, C.L. Keen, and M.E. Gershwin Drug-induced lupus Ann N Y Acad Sci 1108 2007 166 182
104. R.D. Sontheimer, C.L. Henderson, and R.H. Grau Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation Arch Dermatol Res 301 2009 65 70
105. A. Adachi, H. Nagai, and T. Horikawa Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions Dermatology 214 2007 85 88
106. N. Kluger, D. Bessis, and B. Guillot Chronic cutaneous lupus flare induced by systemic 5-flurouracil J Dermatol Treat 17 2006 51 53
107. N. Moazzam, A.A. Malik, S.A. Mehdi, and A. Potti Fluorouracil-induced exacerbation of systemic lupus erythematosus J Clin Oncol 20 2002 3032 3034